首页> 外文期刊>Endocrine >The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men
【24h】

The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men

机译:大麻素受体基因(CNR1)的G1422A变体与肥胖男性的腹部肥胖有关

获取原文
获取原文并翻译 | 示例
           

摘要

Since recent data suggest that the endocannabinoid system controls food intake through central, and lipogenesis via peripheral CB1 receptors, we hypothesized that genetic variation at the cannabinoid receptor-1 (CNR1) locus could have an effect on adiposity. We investigated, whether a specific CNR1 G1422A genotype is associated with anthropometric markers of obesity and fat distribution in adult obese individuals. A total of 1,064 obese subjects (BMI ≥ 30 kg/m2) without diabetes, impaired glucose tolerance or other endocrine diseases and 251 healthy control persons were genotyped for the G1422A variant (rs1049353) with a TaqMan assay. Anthropometric measures as body weight, BMI, waist and waist-to-hip ratio (WHR) were assessed by classical methods. Fat mass (FM) was measured by bio-impedance. The prevalence of the G1422A variant was not significantly different between cases and controls (OR = 1.056; P = 0.626). In obese women, no meaningful associations between CNR1 genotype and anthropometric parameters were found. In obese men, CNR1 1422 A/A genotype was significantly associated with higher WHR (P = 0.009) and waist circumference (P = 0.008) after adjusting for age and BMI. Fat mass percentage showed an association (P = 0.011) which disappeared after adjusting for age and BMI. A trend for an association was seen for fat mass (unadjusted P = 0.099; adjusted P = 0.033). Our data indicate that the G1422A polymorphism in the CNR1 gene is associated with increased abdominal adiposity in obese men.
机译:由于最近的数据表明内源性大麻素系统通过中枢和外围CB1受体来控制食物摄入,因此我们假设大麻素受体1(CNR1)位点的遗传变异可能对肥胖有影响。我们调查了特定的CNR1 G1422A基因型是否与成人肥胖个体中肥胖和脂肪分布的人体测量学标志有关。使用TaqMan分析法对总计1,064名没有糖尿病,糖耐量降低或其他内分泌疾病的肥胖受试者(BMI≥30 kg / m2 )和251名健康对照者进行了G1422A变体(rs1049353)的基因分型。通过经典方法评估人体测量指标,如体重,BMI,腰围和腰臀比(WHR)。脂肪量(FM)通过生物阻抗测量。在病例与对照之间,G1422A变异的患病率无显着差异(OR = 1.056; P = 0.626)。在肥胖妇女中,未发现CNR1基因型与人体测量学参数之间有意义的关联。在肥胖男性中,调整年龄和BMI后,CNR1 1422 A / A基因型与较高的WHR(P = 0.009)和腰围(P = 0.008)显着相关。脂肪质量百分比显示出相关性(P = 0.011),在调整了年龄和BMI后消失了。观察到脂肪量的关联趋势(未调整P = 0.099;已调整P = 0.033)。我们的数据表明,CNR1基因中的G1422A多态性与肥胖男性的腹部肥胖增加有关。

著录项

  • 来源
    《Endocrine》 |2007年第2期|138-141|共4页
  • 作者单位

    Department of Medical Genetics Faculty of Pharmaceutical Biomedical and Veterinary Sciences Antwerp University Universiteitsplein 1 Wilrijk Antwerp 2610 Belgium;

    Department of Medical Genetics Faculty of Pharmaceutical Biomedical and Veterinary Sciences Antwerp University Universiteitsplein 1 Wilrijk Antwerp 2610 Belgium;

    Department of Diabetology Metabolism and Clinical Nutrition Antwerp University Hospital Antwerp Belgium;

    Department of Medical Genetics Faculty of Pharmaceutical Biomedical and Veterinary Sciences Antwerp University Universiteitsplein 1 Wilrijk Antwerp 2610 Belgium;

    Department of Diabetology Metabolism and Clinical Nutrition Antwerp University Hospital Antwerp Belgium;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Association; Polymorphism; Cannabinoid receptor; CNR1; Obesity;

    机译:联想;多态性;大麻素受体;CNR1;肥胖;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号